Search
Displaying 31–40 of 149 for “Visions 2020”
-
VISIONS 2024, the national conference of the Foundation Fighting Blindness, is a one-of-a-kind event in which individuals who are visually impaired, and their families, have the opportunity to hear about exciting advancements in blindness research.
-
Beacon Stories My Retina Tracker Patient Stories
Mark Erelli has been a professional musician for the past twenty-three years. He’s always used songwriting to express himself. Since being diagnosed with retinitis pigmentosa, he’s needed music more than ever.
-
Beacon Stories
The faces behind RP Hope, Save Sight Now, and Sofia Sees Hope are all immensely dedicated to their nonprofit’s missions. The inspiration behind these organizations is similar, but their story and commitment are uniquely personal.
-
Girl Scouts are Changing the World One Crosswalk at a Time
Beacon StoriesInspired by their troop leader diagnosed with Usher syndrome, Girl Scout Troop 1673 is hoping to change the world, one crosswalk at a time, with their Paint It Yellow challenge.
-
Welcome to our livestream series, Music to Our Eyes. In each episode, we sit down with various artists to discuss their experiences with vision loss and discuss their commitment to creating music that celebrates diversity and belonging.
-
Foundation Fighting Blindness to Host Fall National Virtual VisionWalk
Foundation NewsThe Virtual VisionWalk on October 24th will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Foundation News
The event will review best practices for care and management of patients with inherited retinal diseases such as retinitis pigmentosa, Usher syndrome, and Stargardt disease.
-
Foundation News
The inaugural credit-based event will include education on inherited retinal diseases, physician resources, and current clinical trials.
-
The VISIONS Team is working hard to secure some of the world’s best researchers and clinicians in the field of retinal diseases to speak at VISIONS2018.
-
AGTC Reports Positive Six-Month Results for XLRP Phase 1/2 Gene Therapy Trial
Research NewsThe company is planning a Phase 3, pivotal trial for end of 2020
